Beckman Coulter Says Q1 Revenues Rise 8 Percent Atop 12-Percent Jump in Profits | GenomeWeb

Beckman Coulter Says Q1 Revenues Rise 8 Percent Atop 12-Percent Jump in Profits

May 02, 2007

NEW YORK (GenomeWeb News) — Beckman Coulter today said first-quarter revenues increased 8 percent as R&D spending rose 6 percent and profit grew 12 percent.

Total receipts for the three months ended March 31 increased to $613.6 million from $569 million year over year.

Product-related revenue increased 8 percent to $512.4 million while service-related revenue was up 6 percent to $101.2 million. Sales of consumables grew by nearly 13 percent, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Best Options

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

A Butterfly's Wings

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

This Week in PNAS

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Pathogen Tracking

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.